SOLENO THERAPEUTICS INC (NASDAQ:SLNO) filed a Form 8-K with the Securities and Exchange Commission on January 23, 2026, disclosing a material event.
SOLENO THERAPEUTICS INC's stock currently trades at $42.36 with a market capitalization of $2.7B. The Healthcare company's stock moved following the disclosure.